What Happens to Plaque in Your Arteries After Menopause—and Why Is It Important?

What actually changes across the transition

Several things move at once. Lipids shift in an atherogenic direction, commonly described as rising LDL cholesterol and related measures — covered in more depth on cholesterol after menopause. Blood pressure often drifts upward. Body composition and glucose handling change. Measures of arterial structure and stiffness change too.

Because these move together, it is difficult to isolate any single mechanism as “the cause.” What the pattern supports is a practical claim: this is a period when vascular risk is accelerating, so it is a reasonable period to take vascular risk seriously.

Why This Matters for Your Brain

Atherosclerosis is not only a heart issue. The same disease process affects the carotid arteries, the intracranial arteries and the small vessels inside the brain. Disease in arteries supplying the brain, along with the vascular risk factors that drive it, contributes to ischemic stroke and to long-term vascular brain injury that accumulates quietly over years.

That is the reason a menopause and brain health site spends time on cholesterol and blood pressure. Protecting arteries is protecting brain tissue. Our pages on menopause and stroke risk, vascular brain health and hormone therapy and dementia risk follow the same thread from a different angle.

Timing matters here as well. Women who reach menopause earlier have another reason to attend to vascular risk sooner — see early menopause and brain health.

Menopause Is a Cardiovascular Health Checkpoint

Think of this stage as a scheduled review rather than a warning. These are the items worth knowing your own numbers on:

• Blood pressure. Often rising in midlife, frequently without symptoms. See high blood pressure and menopause.
• LDL cholesterol. Know the number and whether your overall risk makes treatment reasonable — see cholesterol after menopause.
• Glucose and diabetes control. Metabolic health is vascular health.
• Smoking. The single most consequential modifiable vascular risk factor to eliminate.
• Physical activity. Regular aerobic activity acts on blood pressure, lipids, glucose and weight at once — see exercise and the brain.
• Weight and overall cardiovascular health. Considered together rather than as a single number.

Where hormone therapy fits — and where it does not

This page is not a recommendation to start, stop or change hormone therapy, and hormone therapy should not be started for the purpose of preventing cardiovascular disease.

The ELITE trial is useful for understanding why timing keeps coming up. Women were randomized to oral estradiol or placebo, stratified by how long they had been postmenopausal. Among women who began treatment within six years of menopause, progression of carotid intima-media thickness was slower than with placebo. Among women who began 10 or more years after menopause, it was not. Measures of coronary artery plaque on CT did not differ significantly between groups.

Read carefully, that is a finding about one imaging measure of subclinical disease and the influence of timing and baseline vascular health — not evidence that hormone therapy prevents heart attacks or strokes. It is one input into an individualized conversation that also weighs symptoms, personal history and other risks. Background on the hormonal side sits on estrogen, progesterone and the brain.

Questions to bring to your clinician

• “What are my current blood pressure, LDL cholesterol and glucose numbers?”
• “Based on my overall risk, does anything on that list need treatment now?”
• “Does my age at menopause change how you think about my cardiovascular risk?”
• “Which of my risk factors would make the biggest difference if I changed it?”
• “If I am considering hormone therapy, how does my vascular health factor in?”
• “How often should we recheck these numbers?”